Notice of Transition to Higher Compatibility Products for the CPU-328LT Series

This is a CPU board equipped with the SH7085 for the 5.7-inch VGA LCD controller "KS-LCTV-2PBI/2PAI."

The "CPU-328LTA-V" is a CPU board equipped with the SH7085, designed as a higher compatibility product for the "CPU-328LT-V" for the "KS-LCTV-2PBI/2PAI". A major feature is that all of Kenic System's backlight DC-DC converters can now be connected (*1). Additionally, the termination resistor for RS-485, which was previously an external component, can now be mounted as a chip resistor in the designated location. This board features the Renesas "SH7085" CPU, along with the LCD controller "KS-LCTV-2PBI/2PAI", Flash-ROM, SRAM, RS-232C, RS-485, E2PROM, and more. (*1) Note that the default brightness setting is "off" only when using KSLBC-2. * For further details, please refer to the datasheet or contact us.

• Other electronic parts

This is a CPU board equipped with the SH7085 for the 5.7-inch QVGA LCD controller "KS-LCTQ-2PBI/2PAI."

The "CPU-328LTA-Q" is a higher compatibility product of the "CPU-328LT-Q." It is a CPU board equipped with the SH7085 for the "KS-LCTQ-2PBI/2PAI." A major feature is that all of Kenic System's backlight DC-DC converters can now be connected (*1). Additionally, the termination resistor for RS-485, which was previously an external component, can now be mounted as a chip resistor in the designated location. This board is equipped with the Renesas "SH7085" CPU, an LCD controller "KS-LCTQ-2PBI/2PAI," Flash ROM, SRAM, RS-232C, RS-485, E2PROM, and more. (*1) Note that the default brightness setting is "off" only when using KSLBC-2. *For further details, please refer to the datasheet or contact us.

• Other electronic parts

Tokyo, August 14, 2025 - (JCN Newswire) - Global consulting firm AlixPartners (hereinafter referred to as "the Company") has conducted a survey of industry experts involved in turnaround and restructuring in Asia and has released the latest report titled "2025 Asia Turnaround & Restructuring Survey" (hereinafter referred to as "the Survey"). The results of this survey indicate that, amidst ongoing geopolitical tensions affecting the economic situation, there is an optimistic outlook in Asia regarding global market instability and uncertainty. On the other hand, over 90% of respondents predict that geopolitical turmoil, such as regime changes and conflicts, will lead to an increase in corporate underperformance in the Asia region. Additionally, about 70% believe that global supply chain challenges will worsen over the next year, indicating that as international circumstances become more complex, the impact of such changes on Asian businesses is expanding. URL https://acnnewswire.com/press-release/japanese/101854/

TOYOROBO Co., Ltd. has signed a general agency agreement with OUNITECH ROBOTICS, a robotics company engaged in the development and manufacturing of AI-powered cleaning robots, effective July 4, 2025. Prior to the domestic launch of 'RoboSweep' in Japan, we have initiated a proof of concept (PoC) at our office location in the complex facility "the SOHO," aimed at verifying and optimizing product performance suitable for the Japanese market. 'RoboSweep' is a robot developed to achieve safe and efficient cleaning operations in various environments such as commercial facilities, office buildings, healthcare and welfare, and sports complexes, equipped with advanced autonomous driving technology and AI algorithms. In this proof of concept (PoC), we will measure and evaluate the effectiveness of obstacle avoidance capabilities, cleaning quality, and operational efficiency within actual facilities, aiming for further optimization of product performance, including the Japanese facility environment and detailed operational capabilities.

The size of the Japanese soup market reached 700 million USD in 2024. Going forward, the IMARC Group predicts that the market will reach 900 million USD by 2033, showing a growth rate (CAGR) of 2.9% between 2025 and 2033. The Japanese soup market is experiencing stable growth, supported by consumer needs for convenience, instant preparation, and health consciousness. Innovations in taste, packaging, and functional ingredients continue to attract a diverse customer base. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is categorized by type, category, packaging, distribution channel, region, and MIMO composition. This report focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. And email: sales@imarcgroup.com

The Japanese LED display market reached 473.13 million USD in 2024. The IMARC Group forecasts that this market will grow at a compound annual growth rate (CAGR) of 11.88% between 2025 and 2033, reaching 1.29942 billion USD by 2033. The Japanese LED display market is steadily growing, supported by increased adoption in advertising, sports, transportation, and entertainment sectors. Advances in technology have improved display quality, energy efficiency, and versatility for a wide range of applications. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is segmented based on technology insights, color insights, application insights, end-user insights, regional insights, and MIMO configuration insights. This report focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. And email: sales@imarcgroup.com

The Japanese biosimilar market reached 475.8 million USD in 2024. Going forward, the IMARC Group predicts that the market size will reach 3.4196 billion USD by 2033, growing at an average annual growth rate of 22.7% from 2025 to 2033. The expansion of the Japanese biosimilar market is driven by the increasing demand for cost-effective biological products and the development of a regulatory framework to support it. The rising adoption of biosimilars in the treatment of oncology, autoimmune diseases, and chronic conditions is propelling market growth. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is segmented based on insights into molecules, indications, and manufacturing types. It focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. Email: sales@imarcgroup.com